Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer

A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy

NCT03086291 ·Status: UNKNOWN ·Phase: PHASE1

Biomarker-Integrated Umbrella, Advanced Gastric Cancer

NCT02951091 ·Status: COMPLETED ·Phase: NA

S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

NCT00343668 ·Status: UNKNOWN ·Phase: PHASE2

Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

NCT00287768 ·Status: COMPLETED ·Phase: PHASE3

Paclitaxel and Irinotecan in Advanced Gastric Cancer

NCT01136031 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer

NCT01152853 ·Status: COMPLETED ·Phase: PHASE2

Second-Line Irinotecan vs. ILF for AGC

NCT00509964 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

NCT01224652 ·Status: UNKNOWN ·Phase: PHASE3

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

NCT06437678 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy

NCT01497964 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

NCT00512681 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression

NCT05512182 ·Status: WITHDRAWN ·Phase: PHASE2

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

NCT02150447 ·Status: TERMINATED ·Phase: PHASE3

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer

NCT01305993 ·Status: UNKNOWN ·Phase: PHASE2

Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

NCT00278863 ·Status: COMPLETED ·Phase: PHASE2

A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer

NCT06706895 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

NCT00072787 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

NCT03042611 ·Status: COMPLETED ·Phase: PHASE3

Predicting Biomarker of Gastric Cancer Chemotherapy Response

NCT03253107 ·Status: RECRUITING

A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

NCT01100801 ·Status: UNKNOWN ·Phase: PHASE2

Predicting the Efficacy in Advanced Gastric Cancer.

NCT06490055 ·Status: COMPLETED

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

NCT03137004 ·Status: UNKNOWN ·Phase: PHASE2

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

NCT06551142 ·Status: RECRUITING ·Phase: PHASE1

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

NCT01917552 ·Status: RECRUITING ·Phase: PHASE3

A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients

NCT05442138 ·Status: UNKNOWN